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Summary
Introduction: Several risk factors for sudden unexplained death in epilepsy patients
(SUDEP) have been proposed, but subsequent work has yielded conflicting data. The
relative importance of various risk factors for SUDEP was never explored. The aim of
this study is to review systematically risk factors for SUDEPand also to determine their
relevance for SUDEP by calculating relative risk factor ratios.
Methods and materials: Authors performed a literature-search on ‘‘SUDEP’’ in Med-
line, the Cochrane Library and EMBASE. Studies with unknown number of SUDEP cases
or with less than five SUDEP cases and reviews were excluded from further analysis.
The value of each paper was assessed, based on the quality of the study and the
reliability of the diagnosis of SUDEP. This value ranged from 1 (low quality) to 10 (high
quality). Papers with a value below 7 were eliminated for further analysis. For each
analysed factor, a risk factor ratio was determined, with a higher ratio for a stronger
risk factor.
Results: A number of strong risk factors for SUDEP: young age, early onset of seizures,
the presence of generalized tonic clonic seizures, male sex and being in bed.Weak risk
factors for SUDEP: prone position, one or more subtherapeutic bloodlevels, being in
the bedroom, a strucural brain lesion and sleeping.
Conclusions: In this study, authors have designed a quality scale to select papers. The
relative importance of risk factors for SUDEP is demonstrated.
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Several potential risk factors for sudden unexpected
death in epilepsy patients (SUDEP) have been inves-
tigated, but results from different studies are con-
flicting and the relative importance of various risk
factors has not been explored in depth.1—35 Review-
ers have tried to summarise the risk factors for SUDEP
but the results were not always consistent. Authors
found the following factors: generalised tonic clonic
seizures,28,36—39 high seizure frequence,28,36,37,39—41
onset of epilepsy at early age,36,39,42 long duration of
epilepsy,36,38,40 polytherapy/high number of antiepi-
leptic drugs (AED),36—38,40 frequent changes of doses
of AED,36 seizure preceding death,40 subtherapeutic
AED levels,40 young age,28,38,40 candidates for epi-
lepsy surgery andepilepsy referral centres,38,40 coex-
isting neurological disease,37 male sex,28,42 poor
compliance with AED,28 history of head trauma,38
alcohol abuse,38 being at home,38 being in bed,38
seizure severity,42 seizure etiology,42 partial onset
seizures.42 Inconsistent and inaccurate death certi-
fication, lack of agreed definitions, different termi-
nology, and different understanding of the same
terminology hamper research into mortality in epi-
lepsy and result in national incidence numbers that
are difficult to interpret.43 In fact, comparisons of
SUDEPratesandresults arenearly impossiblebecause
study variables may include different definitions of
sudden unexpected death in epilepsy, group compo-
sitions or documentation requirements. In addition,
theaccuracyofdiagnosis, theuseofAEDprescriptions
as a marker for epilepsy, the quality of postmortem
data, death certificates that may not mention epi-
lepsy ormay incorrectly state the cause of death, and
selection bias, are some other factors whichmay also
affect the accuracy of SUDEP rates in these studies.44
None of the reviews applied a system of weighing the
evidence of the different studies. The aim of this
paper is to systematically review the risk factors for
SUDEP and to determine the relevance of each risk
factor for SUDEP by weighing the individual studies.Methods and materials
Authors selected good quality studies analysing risk
factors for SUDEP and calculated a risk factor totalstudies ratio (RFT) for each risk factor. The RFT is
given a positive or a negative value based on the
results in the studies analysing the possible risk
factor and corrected for the number of included
SUDEP cases in the different studies (see Table 1).
Authors consider the risk factor a strong risk factor
for SUDEP if RFT  1.0, a weak risk factor for SUDEP
if RFT  0.5 and no risk factor for SUDEP if
RFT < 0.5(Tables 2 and 3).Results
In total, 120 papers were collected (Table 4). Ninety
three papers were excluded (Table 5) leaving 27
papers (908 cases of SUDEP) for further analysis
(Table 6) The results of the analysis of the different
factors are summarised in Fig. 1.1—14,16—26,45,46 A
number of strong risk factors for SUDEP were iden-
tified: young age, early onset of seizures, the pre-
sence of generalized tonic clonic seizures, male sex
and being in bed. Weak risk factors were prone
position, one or more subtherapeutic bloodlevels,
being in the bedroom, a structural brain lesion and
sleeping. Factors not considered to be a risk factor
are summarised in Table 7.Discussion
Authors identified strong risk factors for SUDEP:
young age, early onset of seizures, the presence
of generalized tonic clonic seizures, male sex and
being in bed. Weak risk factors were prone position,
one or more subtherapeutic bloodlevels, being in
the bedroom, a strucural brain lesion and sleep-
ing.1—14,16—26,45,46
In another evidence-based analysis, the main risk
factors were a seizure preceding death, subthera-
peutic AED levels, youth (age 15—30 years), high
seizure frequency (more than 15 seizures per
month), high number of AED (more than two) and
long duration of epilepsy (more than 15 years).40
The different results may be explained by different
definitions of the factors and by a different meth-
odology.
Authors’ methodology has various advantages.
The selection of studies and the determination of
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Table 1 Flowchart for analysis of possible risk factors
Interpretation 
Strong risk factor for SUDEP: RFT≥1.0 
Weak risk factor for SUDEP: RFT≥0.5 
No risk factor for SUDEP: RFT < 0.5
Literature search 
Medline (1965- april 20th 2006), Embase, Cochrane Library     “SUDEP”. 
Selection of papers 
Inclusion if value of a paper > 6 (table 2) a
Exclusion: 
--other language than English, French, German or Dutch  
--animal study  
--reviews  
--papers not analysing risk factors for SUDEP 
--case reports or studies with less than 5 SUDEP-cases  
--number of SUDEP cases not mentioned
All papers were systematically retrieved with an extensive list of factors based on previously mentioned 
possible risk factors (tabel 3) and the risk factor value was determined b :
1 : analysed factor considered as a risk factor for SUDEP. 
-1: analysed factor not considered as a risk factor.  
0: factor was not analysed in the study or controls were matched for the factor.  
Risk factor value (RFV)
For each study that passed the selection, a RFS was calculated per analysed factor:  
RFS = √(number of SUDEP-cases in the study / total number of patients in all selected studies) * RFV 
Risk factor study ratio (RFS)
RFT = ∑ (RFS of analysed factor) 
Risk factor total studies ratio (RFT)
aThe value of each paper was estimated, based on the quality of the study and the reliability of the diagnosis of SUDEP (Table 2). The
quality of the study was expressed in a rating, and depended on the availability of a definition of the population, on the type and
design of study and the number of patients included. The score ranged from 1 to 10; a higher number indicating a better quality of the
study.
bIn case an author did not decide whether a factor was or was not a risk factor for SUDEP, the authors performed the following
procedure: If possible, authors used a x2-test. Otherwise the factor was considered a risk factor for SUDEP in the study in question if
the factor was present in more than 50% of the patients under study. Inconsistencies were discussed in a panel of three authors (CM,
JA, FT). In studies with an inclusion of only children or people less than 45 years of age, authors decided that the RFVof ‘‘young age’’
was zero.the relevance of the risk factor are clear and trans-
parant. Authors only included papers in which the
term ‘‘SUDEP’’ was used. The quality of each study
was expressed as a rating. Authors present a listing
of risk factors by relevance. The relevance of a riskfactor is based on the number of included SUDEP
cases in the different studies and on a positive or a
negative risk factor value, the latter allowing the
authors to use a negative result in a study. In the
review of Te´llez—Zenteno the relevance of a risk
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Table 2 Possible scores assigned to the papers based on the quality of the study and the reliability of the diagnosis of
SUDEP
Item I score M score
Study Definition of population Mentioned 1 1
Not mentioned 0
Study design Cohort analysis/Case control study 1 1
Unknown 0
Prospective Prospective/premortem registration/follow-up 2 2
Retrospective 1
Unknown 0
Number of cases >10 cases 2 2
10 cases 1
SUDEP Definition of SUDEP Mentioned 1 1
Not mentioned 0
Definite SUDEP/autopsy Only definite SUDEP 2 2
Also definite SUDEP 1
Only probable or possible (but no definite) SUDEP 0
SUDEP decided By neurologist/coroner/team of specialists 1 1
Unknown who decides 0
I score: item score; M score: maximum score.
Table 3 Analysed factors for SUDEP
Category Analysed factor
Demography Young age, male sex, black race
Epilepsy Generalised tonic-clonic seizures, high seizure frequency, chronic epilepsy,
symptomatic epilepsy, structural brain lesion, posttraumatic epilepsy,
early onset epilepsy
Psychiatry Recent unusual stressful life event, psychiatric illness, mental retardation,
psychotropic drug prescription, use of antidepressants,
use of anxiolytics, use of antipsychotics, alcohol abuse
Therapy Use of particular anti epileptic drugs (AED), the prescription of carbamazepine,
the prescription of phenytoin, increasing number of AED prescribed,
subtherapeutic AED levels, poor AED compliance, epilepsysurgery,
vagal nerve stimulation
Circumstances of death Lying in bed, sleeping, proneposition, being in bedroom, being outside the house
Other Hyponatriemia, cardiovascular disease
Young age: <45 years at death; high seizure frequency: 1 seizure a month; chronic epilepsy: epilepsy with a duration >10 years;
early onset: <45 years at diagnosis of epilepsy.
Table 5 Excluded papers
Reason for exclusion Numberfactor was based on the percentage of studies in
which the factor was a positive risk factor.40
Authors’ methodology has, however, also some dis-
advantages. To authors’ knowledge, the risk factor
value method has never been validated before but
this is not necessary because authors can assume
that the accuracy of the study increases with theTable 4 Search results for ‘‘SUDEP’’
Database Number
Medline 95
Cochrane library 0
Embase 105
Total 120square root of the number of included patients.
Papers scoring below 7 were discarded. Setting
the bar at 7 was an arbitrary choice of the authors.
Authors are aware that authors might forget toOther language 7
Animal study 6
Reviews 30
Not analysing risk factors for SUDEP 39
Number of SUDEP cases not reported 2
Case report or study with less than five cases 4
Study quality rating less than 7 5
Total 93
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Figure 1 Risk factor total studies ratio (RFT) of possible risk
value based on the results in the studies analysing the possible
cases in the different studies (see Table 1). Authors consider t
weak risk factor for SUDEP if RFT  0.5 and no risk factor for
nerve stimulation, TC seizure: tonic clonic seizure is based.
Table 7 Factors considered to carry no risk for SUDEP
Category Analysed factor
Demographic Black race
Epilepsy Symptomatic epilep
high frequency of s
Psychiatry Recent unusual stre
prescription, use of
mental retardation
Therapy Use of particular AE
of phenytoin, incre
AED, epilepsysurger
Circumstances of death Being outside the h
Other Hyponatriemia, car
Table 6 Included studies (score 7) and number of
SUDEP cases
Beran1 21 Walczak10 20 Ficker20 9
Nei 2 21 Opeskin11 50 Langan21 15
Opeskin3 50 Annegers12 15 Annegers22 8
Nilsson4 10 Langan13 15 Nashef23 26
Salmo5 22 Opeskin14 44 Leestma24 24
Schnabel 6 39 Henessy16 6 Tennis 25 39
Donner7 27 Thom17 10 Coyle26 40
Nilsson8 57 Kloster18 42 Langan45 154
Antoniuk9 20 Nilsson19 57 Learkaul46 67mention some items, but authors can expect that
good studies are properly described. A clear defini-
tion of the population under study is an important
methodological issue and, of course, a study without
a definition of SUDEP is a bad study and will have
more shortcomings. Theoretically, cases of sudden
cardiac death could be included in a paper without
information on the population under study. How-
ever, the authors expect that setting the limit of 7
points has minimized this risk (in fact only five
studies were eventually excluded by this threshold).
When determining the RFT, the authors did not
distinguish between a cohort study and a case con-
trol study, while the value of the evidence fromfactors for SUDEP. The RFT is given a positive or a negative
risk factor and corrected for the number of included SUDEP
he risk factor a strong risk factor for SUDEP if RFT  1.0, a
SUDEP if RFT < 0.5. AED: anti epileptic drugs, VNS: vagal
sy, posttraumatic epilepsy, long duration of epilepsy,
eizures
ssful life event, psychiatric illness, psychotropic drug
antidepressants, use of anxiolytics, alcohol abuse,
D, the prescription of carbamazepine, the prescription
asing number of prescribed AED, poor compliance with
y, vagal nerve stimulation
ouse
diovascular disease
6 C.P.J.A. Monte´ et al.these designs may be very different. Information on
some risk factors is more easily obtained (e.g. male
sex and age at death). The same study population
might have been used in two or more studies. In
both cases there would be a wrongful increase of
the RFT.
A listing of risk factors by relevancemay allow the
authors to differentiate populations at higher and
populations at lower risk for SUDEP. A male patient,
less than 45 years old with a combination of early
onset of seizures the presence of generalized tonic
clonic seizures and a strucural brain lesion is at high
risk for SUDEP. Being in the bedroom or in bed, prone
position, sleeping and or more subtherapeutic
bloodlevels are circumstantial risk factors that
may increase the risk for SUDEP.
Future research on risk factors is still needed and
should be based on a prospective cohort. Due to the
low incidence of SUDEP, this will be a hard thing to
do. More interestingly, understanding the mechan-
ism(s) of SUDEPmay allow the authors to understand
which patients are or are not at high risk for SUDEP
and eventually to prevent SUDEP. Different mechan-
isms were postulated to play a role in SUDEP includ-
ing cardiac arrhytmia precipitated by seizure
discharge acting via the autonomic nervous sys-
tem,47—53 respiratory arrest,54—56 neurogenic pul-
monary oedema57 and asphyxiation.18,23,56 It should
be stressed that authors made a qualitative approx-
imation of strength of risk factors. The more often a
risk factor was considered to be important, themore
likely the risk factor is of relevance. Authors have no
means to estimate the (in)dependencies of the
various risk factors. Most of the risk factors are
unavoidable. Nevertheless, identifying groups at
high risk may allow the authors to inform patients
and to select patients for monitoring when admitted
in epilepsy centers and may also facilitate research
for pathophysiological mechanisms, which remain
unclear until now.References
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